ABAnthony C Becker

Anthony C Becker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anthony C Becker has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Karen Sliwa

    Cape Heart Institute, Faculty of Health Sciences, University of Cape Town , Cape Town

    3 shared publications
  • Simon Stewart

    School of Medicine, The University of Notre Dame, Fremantle, Western Australia, Australia

    3 shared publications
  • E. Libhaber

    Division of Cardiology, Chris Hani Baragwanath Hospital, Johannesburg, South Africa, University of the Witwatersrand, Johannesburg, South Africa

    2 shared publications
  • M.R. Essop

    Division of Cardiology, Chris Hani Baragwanath Hospital, Johannesburg, South Africa, University of the Witwatersrand, Johannesburg, South Africa

    2 shared publications
  • A.R. Essop

    1 shared publication
  • B. Jacobson

    National Health Laboratory Service, School of Pathology, Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg, South Africa

    1 shared publication

Latest Publications

  • Open Access

    Antiphospholipid antibodies in black south africans with hiv and acute coronary syndromes: prevalence and clinical correlates

    by Anthony C Becker, Elena Libhaber, Karen Sliwa, Sham Singh, Simon Stewart, Mohammed Tikly, Mohammed R Essop

    HIV infection is associated with a high prevalence of antiphospholipid antibodies (aPL) and increased thrombotic events but the aetiopathogenic link between the two is unclear.


  • Open Access

    The Thrombotic Profile of Treatment-Naive HIV-Positive Black South Africans With Acute Coronary Syndromes

    by A.C. Becker, B. Jacobson, S. Singh, K. Sliwa, S. Stewart, E. Libhaber, M.R. Essop

    Background: Patients with human immunodeficiency virus (HIV) infection on protease inhibitors (PIs) have a heightened risk of arterial thrombosis but little is known about treatment-naive patients. Methods/Results: Prospective study from South Africa comparing thrombotic profiles of HIV-positive and -negative patients with acute coronary syndrome (ACS). A total of 30 treatment-naive HIV-positive patients with ACS were compared to 30 HIV-negative patients with ACS. Patients with HIV were younger; and besides smoking (73% vs 33%) and low high-density lipoprotein (HDL; 0.8 ± 0.3 vs 1.1 ± 0.4), they had fewer risk factors. Thrombophilia was more common in HIV-positive patients with lower protein C (PC; 82 ± 22 vs 108 ± 20) and higher factor VIII levels (201 ± 87 vs 136 ± 45). Patients with HIV had higher frequencies of anticardiolipin (aCL; 47% vs 10%) and antiprothrombin antibodies (87% vs 21%). Conclusion: Treatment-naive HIV-positive patients with ACS are younger, with fewer traditional risk factors but a greater degree of thrombophilia compared with HIV-negative patients.


  • Acute Coronary Syndromes in Treatment‐Naïve Black South Africans with Human Immunodeficiency Virus Infection

    by A.C. Becker, K. Sliwa, S. Stewart, E. Libhaber, A.R. Essop, C.A. Zambakides, M.R. Essop

    Background: HIV patients on protease inhibitors have greater risk of acute coronary syndromes (ACS) but little is known about treatment‐naïve patients. Methods and Results: Authors conducted a prospective single‐center study from Soweto, South Africa, comparing the clinical and angiographic features of treatment‐naïve HIV positive and negative patients with ACS. Between March 2004 and February 2008, 30 consecutive treatment‐naïve HIV patients with ACS were compared to the next HIV‐negative patient as a 1:1 control. HIV patients were younger (43 ± 7 vs. 54 ± 13, P = 0.004) and, besides smoking (73% vs. 33%, P = 0.002), had fewer risk factors than the control group with less hypertension (23% vs. 77%, P = 0.0001), diabetes (3% vs. 23%, P = 0.05), LDL hyperlipidemia (2.2 ± 0.9 vs. 3.0 ± 1.2, P = 0.006), and other coronary risk factors (7% vs. 53%, P = 0.0001). HDL was lower in the HIV group (0.8 ± 0.3 vs. 1.1 ± 0.4, P = 0.001). Atherosclerotic burden was lower in the HIV group with more normal infarct‐related arteries (47% vs. 13%, P = 0.005) but a higher degree of large thrombus burden (43% vs. 17%, P = 0.02). Stents were used to a similar degree in HIV and control patients (30% vs. 37%, P = 0.78) with more target lesion revascularization in the HIV group (56% vs. 0%, P = 0.008). Conclusion: Treatment‐naïve HIV patients with ACS are younger and have fewer traditional risk factors than HIV‐negative patients. HIV patients have less atherosclerotic but higher thrombotic burden which may imply a prothrombotic state in the pathogenesis of ACS in these patients. (J Interven Cardiol 2010;23:70–77)